Patient skipping thyroid medication for one week. He is suffering from tremors, BP 80/50 mmHg, heart rate 46 bpm. What will be the immediate management for this patient?

Appeared in: NORCET 10 Mains

Explanation

The patient's symptoms (hypotension, bradycardia) after stopping thyroid medication are indicative of myxedema coma, a severe form of hypothyroidism.
Myxedema coma is a life-threatening endocrine emergency where the body's metabolism slows down drastically.
The definitive and most critical immediate treatment is to replace the missing hormone intravenously (IV) to rapidly restore metabolic function.
IV levothyroxine is the standard treatment, as oral absorption may be impaired in these critically ill patients.
While supportive care is essential, hormone replacement is the key intervention that addresses the root cause of the cardiovascular collapse.

Option A: Bradycardia in myxedema coma is due to the severe hypometabolic state, not a primary cardiac conduction issue. It is often unresponsive to atropine.
Option C: While patients with myxedema coma are at high risk for respiratory failure and may eventually need intubation, it is not the first-line intervention unless there is evidence of respiratory distress, apnea, or inability to protect the airway. The question does not provide this information.
Option D: Although the patient is hypotensive, fluid administration is a supportive measure, not the definitive treatment. Furthermore, fluids must be given cautiously in myxedema coma due to the risk of fluid retention and dilutional hyponatremia. The hypotension is unlikely to resolve with fluids alone without hormone replacement.

Clinical Relevance

Nursing practice connection: Knowing Emergency management of myxedema coma helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
Recognizing myxedema coma is a critical nursing skill. It is often triggered by infection, surgery, or, as in this case, medication non-compliance.
Nurses must prioritize interventions. While stabilizing circulation (C) is vital, in myxedema coma, the cause of the circulatory collapse must be treated simultaneously. This involves administering IV thyroid hormone and hydrocortisone promptly.
Patient education on the lifelong nature of thyroid replacement therapy and the dangers of abruptly stopping medication is a key nursing responsibility to prevent such emergencies.

How to Approach the Question

First, analyze the patient's clinical data: history of skipping thyroid medication, hypotension (BP 80/50), and bradycardia (HR 46).
Synthesize these findings to form a likely diagnosis. The combination strongly suggests myxedema coma, a severe complication of hypothyroidism.
Evaluate the question, which asks for the 'immediate management'. This requires you to prioritize interventions.
Consider each option in the context of myxedema coma. Does the intervention treat a symptom or the underlying cause?
Option A (atropine) and D (fluid) treat symptoms (bradycardia, hypotension) but are often ineffective without addressing the cause. Option C (intubation) is for respiratory failure, which isn't specified.
Option B (IV thyroid medicine) directly treats the root cause of the entire life-threatening syndrome. In endocrine emergencies, treating the underlying hormonal imbalance is the definitive priority.

Concept Tested & Keywords

Concept Tested: Emergency management of myxedema coma
Stem keywords: thyroid medication, tremors, BP 80/50 mmHg, heart rate 46 bpm, immediate management
Lead-in keywords: What will be the immediate management
Clinical cues: History of skipping thyroid medication for a week points to a cause.
Clinical cues: Combination of severe hypotension and bradycardia indicates cardiovascular collapse.

QhgKMR25e1w0_lA87cBPB2

E6 Nursing Brunner Adult Health 3SA Vol 1 Part 4 p. 16-18

E6 Medicine Harrison 22e Part 2 p. 936-938

Practise the full NORCET 10 Mains

Attempt every question from this paper in a timed mock, then review the full solution for each one.